| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.024 | 0.9 |